Assessment of Clinical Time Intervals Along the Patient Journey with Overall Survival in Localized Osteosarcoma and Ewing Sarcoma: A 20-Year Tertiary Sarcoma Centre Experience
Timeline Trends: Post-referral clinical timelines in the management of localized osteosarcoma and Ewing’s sarcoma have progressively lengthened over the past two decades, driven primarily by longer intervals between histological diagnosis and treatment initiation.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Revisiting CDKN2A dysregulation in Ewing sarcoma
- Emerging therapies in Ewing sarcoma
- Genome‑wide association study meta‑analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of risk
- Biochemists discover new strategy to combat pediatric bone cancer
- Integrated Immunotherapy Target Atlas for Ewing Sarcoma